Clarus Therapeutics Holdings Inc - Class A
Research Clarus Therapeutics Holdings Inc - Class A (BLUW) on Bullrun: market cap USD 336.00M, P/E 38.2. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBLUW
- ExchangeNASDAQ
- CountryUnited States
- SectorFinancial Services
- IndustryShell Companies
- CurrencyUSD
- Market capUSD 336.00M
- P/E38.2
- Financial periodQ2 2026
- RevenueUSD 0
- Net incomeUSD 2.10M
- Free cash flow-USD 387.85K
Valuation Snapshot
latest market cap is USD 336.00M; P/E is 38.2.
Peer valuation comparison
Latest P/E is 38.15x versus a Financial Services sector median of 13.41x (184.5% above).
Latest P/E is 38.15x versus a United States median of 23.75x (60.7% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | USD 4.67M | -USD 938.88K | n/a | 0.23 | USD 0 | USD 242.40K | -USD 8.93M |
| FY2024 | USD 0 | -USD 48.54K | USD 0 | n/a | 0 | USD 0 | USD 1.51K | -USD 23.54K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 336.00M | 38.2 | n/a | n/a |
| 2025 | 2025-12-31 | USD 333.42M | 64.5 | n/a | n/a |
About Clarus Therapeutics Holdings Inc - Class A
Blue Water Acquisition Corp. III does not have significant operations. The company focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It intends to target businesses in the artificial intelligence, biotechnology, healthcare, and technology sectors. Blue Water Acquisition Corp. III was incorporated in 2024 and is based in Mountainside, New Jersey.
Related stock research
Other Financial Services stocks
Frequently asked questions
What is Clarus Therapeutics Holdings Inc - Class A's market cap?
Clarus Therapeutics Holdings Inc - Class A's market capitalization is USD 336.00M.
What is Clarus Therapeutics Holdings Inc - Class A's P/E ratio?
Clarus Therapeutics Holdings Inc - Class A's price-to-earnings (P/E) ratio is 38.2.
What does Clarus Therapeutics Holdings Inc - Class A do?
Blue Water Acquisition Corp. III does not have significant operations. The company focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It intends to target businesses in the artificial intelligence, biotechnology, healthcare, and technology sectors. Blue Water Acquisition Corp. III was incorporated in 2024 and is based in Mountainside, New Jersey.